Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2018-06-18
Summary
Recent research on the effects of nicotine on the brain and behavior presents an opportunity to advance medication development.
The purpose of this study is to develop a laboratory model for early-stage testing of new and existing treatments for nicotine addiction. Specifically, the investigators will develop a laboratory model of relapse to cigarette use in nicotine dependent volunteers.
Conditions
- Tobacco Use Disorder
Interventions
- BEHAVIORAL
-
Neutral or active cigarette cues
Packets of cigarettes or cigarette smoke.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
New York State Psychiatric Institute
lead OTHER
Principal Investigators
-
Adam Bisaga, M.D. · New York State Psychiatric Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
- Primary Completion
- 2006-06-30
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Electronic Cigarettes in Daily Dependent Smokers
NCT02108626 ·Status: COMPLETED ·Phase: PHASE4
-
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960 ·Status: COMPLETED ·Phase: NA
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment for Nicotine Addiction in Women
NCT02448654 ·Status: COMPLETED ·Phase: NA
-
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
NCT01495819 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
NCT00616746 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Nicotine, Non-Smokers With and Without ADHD, and Genetics Study
NCT01819259 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
NCT01188967 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
Smoking Relapse Prevention in Schizophrenia
NCT00320697 ·Status: COMPLETED ·Phase: PHASE4
-
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
NCT00699556 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varenicline on Reactivity to Smoking and Drinking Cues
NCT00873535 ·Status: COMPLETED ·Phase: NA
-
Relapse Prevention Study in Newly Abstinent Smokers
NCT00793468 ·Status: WITHDRAWN ·Phase: PHASE2
-
Very Low-Nicotine Cigarettes in Smokers With SUD
NCT01989507 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
NCT03692078 ·Status: COMPLETED ·Phase: NA
-
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852 ·Status: COMPLETED ·Phase: NA
-
Role of Metabolites in Nicotine Dependence (2) - 5
NCT00000288 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Imaging in Tobacco Smokers During a Quit Attempt
NCT04055467 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
NCT00046813 ·Status: TERMINATED ·Phase: PHASE4
-
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
NCT00756275 ·Status: COMPLETED ·Phase: NA